{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T11:40:33Z","timestamp":1773402033507,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007277","name":"Icahn School of Medicine at Mount Sinai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007277","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005301","name":"American College of Surgeons","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005301","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jocn.2024.110763","type":"journal-article","created":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T01:37:33Z","timestamp":1721871453000},"page":"110763","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Geriatric grade 2 and 3 gliomas: A national cancer database analysis of demographics, treatment utilization, and survival"],"prefix":"10.1016","volume":"127","author":[{"given":"Mert","family":"Karabacak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Behnam","family":"Jazayeri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pemla","family":"Jagtiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Mavridis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Carrasquilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymund L.","family":"Yong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Margetis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2024.110763_b0005","doi-asserted-by":"crossref","unstructured":"Ostrom QT, Price M, Neff C, Cioffi G, Waite KA, Kruchko C, et al. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2016\u20142020. Neuro-Oncology 2023;25:iv1\u201399. https:\/\/doi.org\/10.1093\/neuonc\/noad149.","DOI":"10.1093\/neuonc\/noad149"},{"key":"10.1016\/j.jocn.2024.110763_b0010","first-page":"1","article-title":"Epidemiology of Gliomas","volume":"vol. 163","author":"Ostrom","year":"2015"},{"key":"10.1016\/j.jocn.2024.110763_b0015","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO Classification of Tumors of the Central Nervous System: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.jocn.2024.110763_b0020","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1200\/EDBK_238353","article-title":"Management for Different Glioma Subtypes: Are All Low-Grade Gliomas Created Equal?","author":"Tom","year":"2019","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.jocn.2024.110763_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.102124","article-title":"A basic review on systemic treatment options in WHO grade II-III gliomas","volume":"92","author":"Mair","year":"2021","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.jocn.2024.110763_b0030","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41374-021-00667-6","article-title":"Grading of adult diffuse gliomas according to the 2021 WHO Classification of Tumors of the Central Nervous System","volume":"102","author":"Komori","year":"2022","journal-title":"Lab Invest"},{"key":"10.1016\/j.jocn.2024.110763_b0035","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s11060-010-0500-6","article-title":"Age as an independent prognostic factor in patients with glioblastoma: a radiation therapy oncology group and American College of Surgeons National Cancer Data Base comparison","volume":"104","author":"Siker","year":"2011","journal-title":"J Neurooncol"},{"key":"10.1016\/j.jocn.2024.110763_b0040","doi-asserted-by":"crossref","first-page":"e496","DOI":"10.1016\/j.wneu.2020.01.041","article-title":"Risk Factors for Early Mortality Among Patients with Glioma: A Population-Based Study","volume":"136","author":"Zhou","year":"2020","journal-title":"World Neurosurg"},{"key":"10.1016\/j.jocn.2024.110763_b0045","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/neuonc\/not043","article-title":"Malignant astrocytomas of elderly patients lack favorable molecular markers: an analysis of the NOA-08 study collective","volume":"15","author":"Wiestler","year":"2013","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.jocn.2024.110763_b0050","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/neuonc\/nop066","article-title":"Prevalence estimates for primary brain tumors in the United States by age, gender, behavior, and histology","volume":"12","author":"Porter","year":"2010","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.jocn.2024.110763_b0055","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1097\/00006123-200112000-00002","article-title":"Age and Radiation Response in Glioblastoma Multiforme","volume":"49","author":"Barker","year":"2001","journal-title":"Neurosurgery"},{"key":"10.1016\/j.jocn.2024.110763_b0060","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s11060-017-2537-2","article-title":"Analysis of factors influencing the access to concomitant chemo-radiotherapy in elderly patients with high grade gliomas: role of MMSE, age and tumor volume","volume":"134","author":"Di Cristofori","year":"2017","journal-title":"J Neurooncol"},{"key":"10.1016\/j.jocn.2024.110763_b0065","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.3171\/2019.6.JNS19409","article-title":"Impact of facility type and volume in low-grade glioma outcomes","volume":"133","author":"Zhu","year":"2020","journal-title":"J Neurosurg"},{"key":"10.1016\/j.jocn.2024.110763_b0070","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s40336-022-00489-6","article-title":"Epidemiology, risk factors, and prognostic factors of gliomas","volume":"10","author":"Pellerino","year":"2022","journal-title":"Clin Transl Imaging"},{"key":"10.1016\/j.jocn.2024.110763_b0075","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1001\/jamasurg.2018.0492","article-title":"Practical guide to surgical data sets: national cancer database (NCDB)","volume":"153","author":"Merkow","year":"2018","journal-title":"JAMA Surg"},{"key":"10.1016\/j.jocn.2024.110763_b0080","doi-asserted-by":"crossref","DOI":"10.18637\/jss.v045.i03","article-title":"Groothuis-Oudshoorn K. mice, multivariate Imputation by Chained Equations in R","volume":"45","author":"Buuren","year":"2011","journal-title":"J Stat Soft"},{"key":"10.1016\/j.jocn.2024.110763_b0085","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s11060-023-04286-7","article-title":"Demographic variations and time to initiation of adjunct treatment following surgical resection of anaplastic astrocytoma in the United States: a National Cancer Database analysis","volume":"162","author":"Sharma","year":"2023","journal-title":"J Neurooncol"},{"key":"10.1016\/j.jocn.2024.110763_b0090","doi-asserted-by":"crossref","first-page":"17380","DOI":"10.1038\/s41598-021-96832-4","article-title":"Age is associated with unfavorable neuropathological and radiological features and poor outcome in patients with WHO grade 2 and 3 gliomas","volume":"11","author":"Krigers","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jocn.2024.110763_b0095","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1016\/j.wneu.2021.08.034","article-title":"Socioeconomic Status and Adult Gliomas Mortality Risk: An Observational Study Based on SEER Data","volume":"155","author":"Che","year":"2021","journal-title":"World Neurosurg"},{"key":"10.1016\/j.jocn.2024.110763_b0100","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s11060-020-03604-7","article-title":"Adjuvant radiation for WHO grade II and III intracranial meningiomas: insights on survival and practice patterns from a National Cancer Registry","volume":"149","author":"Brown","year":"2020","journal-title":"J Neurooncol"},{"key":"10.1016\/j.jocn.2024.110763_b0105","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1001\/jama.2017.5702","article-title":"Association Between Teaching Status and Mortality in US Hospitals","volume":"317","author":"Burke","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jocn.2024.110763_b0110","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1200\/JCO.2005.04.6078","volume":"24","author":"van den Bent","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jocn.2024.110763_b0115","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1056\/NEJMoa1500925","article-title":"Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma","volume":"374","author":"Buckner","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocn.2024.110763_b0120","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/S0140-6736(17)31442-3","article-title":"Interim results from the CATNON trial (EORTC study 26053\u201322054) of treatment with concurrent and adjuvant temozolomide for 1p\/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study","volume":"390","author":"van den Bent","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jocn.2024.110763_b0125","doi-asserted-by":"crossref","unstructured":"Horbinski C, Nabors LB, Portnow J, Baehring J, Bhatia A, Bloch O, et al. NCCN Guidelines\u00ae Insights: Central Nervous System Cancers, Version 2.2022. J Natl Compr Canc Netw 2023;21:12\u201320. https:\/\/doi.org\/10.6004\/jnccn.2023.0002.","DOI":"10.6004\/jnccn.2023.0002"},{"key":"10.1016\/j.jocn.2024.110763_b0130","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1016\/j.wneu.2023.02.099","article-title":"Analysis of Prognostic Factors and Surgical Management of Elderly Patients with Low-Grade Gliomas","volume":"176","author":"Wu","year":"2023","journal-title":"World Neurosurg"},{"key":"10.1016\/j.jocn.2024.110763_b0135","doi-asserted-by":"crossref","DOI":"10.1177\/1756285617752039","article-title":"Current therapeutic approaches to diffuse grade II and III gliomas","volume":"11","author":"Picca","year":"2018","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.jocn.2024.110763_b0140","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/neuonc\/not142","article-title":"Codeletions at 1p and 19q predict a lower risk of pseudoprogression in oligodendrogliomas and mixed oligoastrocytomas","volume":"16","author":"Lin","year":"2014","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.jocn.2024.110763_b0145","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1001\/jamaoncol.2018.1977","article-title":"Association of MGMT Promoter Methylation Status With Survival Outcomes in Patients With High-Risk Glioma Treated With Radiotherapy and Temozolomide: An Analysis From the NRG Oncology\/RTOG 0424 Trial","volume":"4","author":"Bell","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jocn.2024.110763_b0150","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s00401-010-0777-8","article-title":"Absence of IDH mutation identifies a novel radiologic and molecular subtype of WHO grade II gliomas with dismal prognosis","volume":"120","author":"Metellus","year":"2010","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.jocn.2024.110763_b0155","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s11060-019-03313-w","article-title":"Association between extent of resection on survival in adult brainstem high-grade glioma patients","volume":"145","author":"Doyle","year":"2019","journal-title":"J Neurooncol"},{"key":"10.1016\/j.jocn.2024.110763_b0160","doi-asserted-by":"crossref","DOI":"10.1093\/neuonc\/nou153","article-title":"New concepts in the management of diffuse low-grade glioma: Proposal of a multistage and individualized therapeutic approach","author":"Duffau","year":"2014","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.jocn.2024.110763_b0165","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1200\/JCO.2007.13.9337","article-title":"Role of Extent of Resection in the Long-Term Outcome of Low-Grade Hemispheric Gliomas","volume":"26","author":"Smith","year":"2008","journal-title":"JCO"},{"key":"10.1016\/j.jocn.2024.110763_b0170","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s11060-008-9669-3","article-title":"Low-grade gliomas in older patients: a retrospective analysis of prognostic factors","volume":"90","author":"Pouratian","year":"2008","journal-title":"J Neurooncol"},{"key":"10.1016\/j.jocn.2024.110763_b0175","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/COC.0b013e31825d580a","article-title":"Adult Low-grade Glioma: 19-year Experience at a Single Institution","volume":"36","author":"Youland","year":"2013","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.jocn.2024.110763_b0180","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1093\/neuonc\/noaa021","article-title":"Final report from Intergroup NCCTG 86\u201372-51 (Alliance): a phase III randomized clinical trial of high-dose versus low-dose radiation for adult low-grade glioma","volume":"22","author":"Breen","year":"2020","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.jocn.2024.110763_b0185","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.3171\/2014.10.FOCUS14651","article-title":"Proposed therapeutic strategy for adult low-grade glioma based on aggressive tumor resection","volume":"38","author":"Nitta","year":"2015","journal-title":"FOC"},{"key":"10.1016\/j.jocn.2024.110763_b0190","doi-asserted-by":"crossref","unstructured":"Cancer Genome Atlas Research Network, Brat DJ, Verhaak RGW, Aldape KD, Yung WKA, Salama SR, et al. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med 2015;372:2481\u201398. https:\/\/doi.org\/10.1056\/NEJMoa1402121.","DOI":"10.1056\/NEJMoa1402121"},{"key":"10.1016\/j.jocn.2024.110763_b0195","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/nop\/npy014","article-title":"Patterns and disparities of care in glioblastoma","volume":"6","author":"Dressler","year":"2019","journal-title":"Neuro-Oncology Practice"},{"key":"10.1016\/j.jocn.2024.110763_b0200","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s11060-020-03480-1","article-title":"Geographic disparities in access to glioblastoma treatment based on Hispanic ethnicity in the United States: insights from a national database","volume":"147","author":"Lu","year":"2020","journal-title":"J Neurooncol"},{"key":"10.1016\/j.jocn.2024.110763_b0205","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","article-title":"The 2007 WHO Classification of Tumours of the Central Nervous System","volume":"114","author":"Louis","year":"2007","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.jocn.2024.110763_b0210","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096758682400290X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096758682400290X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T12:53:47Z","timestamp":1762347227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096758682400290X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":42,"alternative-id":["S096758682400290X"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2024.110763","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Geriatric grade 2 and 3 gliomas: A national cancer database analysis of demographics, treatment utilization, and survival","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2024.110763","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110763"}}